15:48 ET Andrx gets FDA approval for generic Tiazac (ADRX) 12.41 +0.75: Announces that the FDA has approved the marketing of its Abbreviated New Drug Application for generic Tiazac, to be marketed under the name Taztia. (Tiazac is manufactured by BVF, marketed by FRX, and had 2002 U.S. sales of $270 mln.)
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.